← Back to Clinical Trials
Recruiting NCT06575582

NCT06575582 Digital Navigators for Acceptance and Competence Development with Mental Health Apps

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06575582
Status Recruiting
Phase
Sponsor Medizinische Hochschule Brandenburg Theodor Fontane
Condition Acceptability of Health Care
Study Type INTERVENTIONAL
Enrollment 116 participants
Start Date 2024-07-15
Primary Completion 2025-05-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Support from Digital Navigators to Treatment TeamSupport from Digital Navigators to PatientsTraining for Digital Navigators

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 116 participants in total. It began in 2024-07-15 with a primary completion date of 2025-05-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to learn if and how so called "Digital Navigators" (DN) can help general practitioners, outpatient psychiatrists and psychologists as well as their treated patients to use digital mental health apps (DiGAs) and integrate it into their treatment. The main questions it aims to answer are: * What are the chances and implementation barriers of DN? * What are the acceptance and expectations towards DN? * Do DN affect the psychological health of patients? * Do DN affect the digital health literacy and technical competence of participants? Employees of medical teams (e.g. medical assistants) receive training to become a DN. Afterwards patients are accompanied and supported by the DN for 12 weeks to select and use a suitable app for their mental disorder.

Eligibility Criteria

Inclusion Criteria: * Main diagnosis according to ICD 10 F00-F69, F80-F99 * Capacity to consent is given * Sufficient language skills for an interview in German * Participants have access to modern digital hardware (smartphone) * Basic knowledge of how to operate a smartphone Exclusion Criteria: * Acute danger to self or others * Patients have received prompt (\<= 3 weeks) qualified psychiatric or psychotherapeutic treatment * Severe organic brain diseases with cognitive deficits * Intellectual disability

Contact & Investigator

Central Contact

Julian Schwarz, MD

✉ Julian.Schwarz@mhb-fontane.de

📞 +49 (0) 33638 83501

Principal Investigator

Martin Heinze, Prof

STUDY CHAIR

Medizinische Hochschule Brandenburg Theodor Fontane

Frequently Asked Questions

Who can join the NCT06575582 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Acceptability of Health Care. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06575582 currently recruiting?

Yes, NCT06575582 is actively recruiting participants. Contact the research team at Julian.Schwarz@mhb-fontane.de for enrollment information.

Where is the NCT06575582 trial being conducted?

This trial is being conducted at Brandenburg an der Havel, Germany, Eberswalde, Germany, Fürstenwalde, Germany, Fürstenwalde, Germany and 2 additional locations.

Who is sponsoring the NCT06575582 clinical trial?

NCT06575582 is sponsored by Medizinische Hochschule Brandenburg Theodor Fontane. The principal investigator is Martin Heinze, Prof at Medizinische Hochschule Brandenburg Theodor Fontane. The trial plans to enroll 116 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology